142 related articles for article (PubMed ID: 1790953)
1. [Surgical treatment of ovarian cancer: comparison of primary and secondary tumor reduction interventions].
Kuhn W; Jänicke F; Hölscher M; Schüle G; Pache L; Graeff H
Gynakol Rundsch; 1991; 31 Suppl 2():276-80. PubMed ID: 1790953
[No Abstract] [Full Text] [Related]
2. [Secondary surgical interventions in ovarian cancer].
Jänicke F; Kuhn W; Hölscher M; Graeff H
Gynakol Rundsch; 1991; 31 Suppl 2():26-34. PubMed ID: 1790947
[No Abstract] [Full Text] [Related]
3. [Para-aortic lymph node recurrence of struma tumors and germ cell tumors of the ovary].
Petru E; Pickel H; Lahousen M; Heydarfadai M; Auner J
Gynakol Rundsch; 1991; 31 Suppl 2():274-5. PubMed ID: 1665137
[No Abstract] [Full Text] [Related]
4. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
[TBL] [Abstract][Full Text] [Related]
5. [Status of lymph node excision in surgical treatment of ovarian cancer].
Lahousen M; Stettner H; Pickel H
Gynakol Rundsch; 1990; 30 Suppl 1():30-3. PubMed ID: 2079294
[No Abstract] [Full Text] [Related]
6. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE
Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
[TBL] [Abstract][Full Text] [Related]
7. [Lymphadenectomy in the treatment of malignant ovarian germ cell tumor].
Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):743-8. PubMed ID: 16447650
[TBL] [Abstract][Full Text] [Related]
8. [Conservative surgical treatment of supraglottic cancer and lymph node metastases].
Pignataro O
Arch Otorhinolaryngol Suppl; 1991; 1():23-9. PubMed ID: 1867568
[No Abstract] [Full Text] [Related]
9. Recurrent ovarian carcinoma of low malignant potential: the role of secondary surgical cytoreduction and the prognosis in Chinese patients.
Zang RY; Yang WT; Shi DR; Xing Y; Cai SM
J Surg Oncol; 2005 Jul; 91(1):67-72. PubMed ID: 15999350
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma.
Salani R; Diaz-Montes T; Giuntoli RL; Bristow RE
Ann Surg Oncol; 2007 Dec; 14(12):3552-7. PubMed ID: 17896149
[TBL] [Abstract][Full Text] [Related]
11. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer.
Rufián S; Muñoz-Casares FC; Briceño J; Díaz CJ; Rubio MJ; Ortega R; Ciria R; Morillo M; Aranda E; Muntané J; Pera C
J Surg Oncol; 2006 Sep; 94(4):316-24. PubMed ID: 16917864
[TBL] [Abstract][Full Text] [Related]
12. [Secondary debulking operation in ovarian cancer].
Jänicke F; Schattenmann G; Kuhn W; Graeff H; Siewert JR
Chirurg; 1994 Jan; 65(1):10-7. PubMed ID: 8149793
[No Abstract] [Full Text] [Related]
13. Surgical staging of ovarian low malignant potential tumors.
Rao GG; Skinner E; Gehrig PA; Duska LR; Coleman RL; Schorge JO
Obstet Gynecol; 2004 Aug; 104(2):261-6. PubMed ID: 15291997
[TBL] [Abstract][Full Text] [Related]
14. Relapse and survival in early-stage ovarian cancer.
Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
[TBL] [Abstract][Full Text] [Related]
15. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
[TBL] [Abstract][Full Text] [Related]
16. [Second-look and third-look laparotomies in follow-up of ovarian cancer. A critical review of 6 years' experience].
Schneider J; Erasun F; Hervas JL; Miñambres JL
Zentralbl Gynakol; 1987; 109(4):235-42. PubMed ID: 3591059
[TBL] [Abstract][Full Text] [Related]
17. [Surgical therapy of progressive or recurrent malignant ovarian tumors].
Teufel G; Nicolai M; Aisslinger U; Simonis H; Meerpohl HG; Pfleiderer A
Geburtshilfe Frauenheilkd; 1991 Mar; 51(3):186-93. PubMed ID: 1711489
[TBL] [Abstract][Full Text] [Related]
18. Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease--results from a review of 82 consecutive cases diagnosed between 1992 and 2004.
Jabbour J; Cumming R; Scolyer RA; Hruby G; Thompson JF; Lee S
Ann Surg Oncol; 2007 Jun; 14(6):1943-52. PubMed ID: 17356954
[TBL] [Abstract][Full Text] [Related]
19. Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors?
Cho YH; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
Gynecol Oncol; 2006 Dec; 103(3):878-82. PubMed ID: 16859736
[TBL] [Abstract][Full Text] [Related]
20. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
